APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF FENTANYL-BASED AGENTS
    2.
    发明公开
    APPARATUS AND METHOD FOR TRANSDERMAL DELIVERY OF FENTANYL-BASED AGENTS 审中-公开
    用于透皮递送基于芬太尼的药剂的装置和方法

    公开(公告)号:EP1737434A2

    公开(公告)日:2007-01-03

    申请号:EP05725916.0

    申请日:2005-03-18

    申请人: ALZA CORPORATION

    IPC分类号: A61K9/70

    摘要: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers. In one embodiment, the fentanyl-based agent is contained in a biocompatible coating that is applied to the microprojection member. In a further embodiment, the delivery system includes a gel pack having a fentanyl-based agent­containing hydrogel formulation that is disposed on the microprojection member after application to the skin of a patient. In an alternative embodiment, the fentanyl-based agent is contained in both the coating and the hydrogel formulation.

    摘要翻译: 一种用于透皮递送生物活性剂的设备和方法,该设备和方法包括具有微突出物构件(或系统)的递送系统,所述微突出物构件(或系统)包括适于刺穿角质层进入下面的表皮层的多个微突出物(或其阵列) 表皮和真皮层。 在一个实施方案中,基于芬太尼的药剂被包含在施用于微喷射体元件的生物相容涂层中。 在进一步的实施方案中,递送系统包括具有基于芬​​太尼的药剂的含水凝胶制剂的凝胶组合物,其在施用于患者皮肤之后置于微喷射体构件上。 在另一个实施方案中,基于芬太尼的试剂包含在包衣和水凝胶制剂中。

    FREQUENCY ASSISTED TRANSDERMAL AGENT DELIVERY METHOD AND SYSTEM
    5.
    发明公开
    FREQUENCY ASSISTED TRANSDERMAL AGENT DELIVERY METHOD AND SYSTEM 审中-公开
    量系指透皮给药频率促进的方法和系统

    公开(公告)号:EP1706176A2

    公开(公告)日:2006-10-04

    申请号:EP04795994.5

    申请日:2004-10-21

    申请人: ALZA CORPORATION

    IPC分类号: A61N1/30

    摘要: An apparatus and method for transdermally delivering a biologically active agent comprising a delivery system having a microprojection member (or system) that includes a plurality of microprojections (or array thereof) that are adapted to pierce through the stratum corneum into the underlying epidermis layer, or epidermis and dermis layers, a formulation containing the biologically active agent and an oscillation inducing device. In one embodiment, the biologically active agent is contained in a biocompatible coating that is applied to the microprojection member. In a further embodiment, the delivery system includes a gel pack having an agent-containing hydrogel formulation that is disposed on the microprojection member after application to the skin of a patient. In an alternative embodiment, the biologically active agent is contained in both the coating and the hydrogel formulation.